CS MEDICA A/S · ISIN: DK0061668225 · EQS - Company News

CS MEDICA Stock Now Also Traded on XETRA

The shares of CS MEDICA A/S (ISIN DK0061668225) have been listed on the Frankfurt Stock Exchange since March 2, 2023. The company, a MedTech pioneer in the development of medical devices that benefit from bioactive CBD, has mandated the private bank Hauck Aufhäuser Lampe to include the company's shares in Deutsche Börse AG's trading venue XETRA and ensure continuous trading. As of today, the 12,322,635 registered shares of the company can now also be traded via the electronic trading system XETR...

NGM:CSMED Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News CS MEDICA A/S

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (1)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
01 July 2024 12:02PM
CS MEDICA Stock Now Also Traded on XETRA
DK0061668225
The shares of CS MEDICA A/S (ISIN DK0061668225) have been listed on the Frankfurt Stock Exchange since March 2, 2023. The company, a MedTech pioneer in the development of medical devices that benefit from bioactive CBD, has mandated the private bank Hauck Aufhäuser Lampe to include the company's shares in Deutsche Börse AG's trading venue XETRA and...
CS MEDICA A/S
About the publication
17 June 2024 03:35PM
CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel
DK0061668225
  Strategic Milestone Achieved as CANNORDIC, a CS MEDICA Subsidiary, Navigates Regulatory Challenges to Expand Global Footprint   CS MEDICA Group, a leader in innovative substance-based medical devices containing bioactive CBD, is proud to announce the successful completion of the product registration process for its entire CANNASEN® portfolio o...
CS MEDICA A/S
About the publication
17 June 2024 03:35PM
CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel
DK0061668225
  Strategic Milestone Achieved as CANNORDIC, a CS MEDICA Subsidiary, Navigates Regulatory Challenges to Expand Global Footprint   CS MEDICA Group, a leader in innovative substance-based medical devices containing bioactive CBD, is proud to announce the successful completion of the product registration process for its entire CANNASEN® portfolio o...
CS MEDICA A/S
About the publication
10 June 2024 02:06PM
CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S
DK0061668225
CS MEDICA A/S, a pioneering MedTech company specializing in innovative substance-based medical devices containing bioactive CBD, today announced its plans to spin off and list its subsidiary CANNORDIC A/S on the German Stock Market (Intention to Float).   CS MEDICA ("CS MEDICA" or "The Company") aims to elevate the value of CS MEDICA's shares, ta...
CS MEDICA
About the publication
More CS MEDICA A/S related information
Type Total Last Made by Go to
Corporate Research 1 4th November 2024 EQS Group AG Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN